Characteristics and clinical outcomes of patients with acute heart failure with a supranormal left ventricular ejection fraction-Reference-Cited by-同舟云学术

Characteristics and clinical outcomes of patients with acute heart failure with a supranormal left ventricular ejection fraction

Published:2022-10-02 Issue:1 Volume:25 Page:35-42
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:European J of Heart Fail

Author:

van Essen Bart J.¹,Tromp Jasper¹²³,ter Maaten Jozine M.¹,Greenberg Barry H.⁴,Gimpelewicz Claudio⁵,Felker G. Michael⁶,Davison Beth A.⁷⁸,Severin Thomas⁵,Pang Peter S.⁹,Cotter Gad⁷⁸,Teerlink John R.¹⁰,Metra Marco¹¹,Voors Adriaan A.¹

Affiliation:

1. Department of Cardiology, University of Groningen University Medical Center Groningen Groningen The Netherlands

2. Saw Swee Hock School of Public Health National University of Singapore & the National University Health System Singapore

3. Duke‐NUS Medical School Singapore

4. University of California San Diego San Diego CA USA

5. Novartis Pharma Basel Switzerland

6. Division of Cardiology Duke University School of Medicine Durham NC USA

7. Momentum Research Inc. Chapel Hill NC USA

8. Inserm U 942 (MASCOT) Hopital Lariboisière Paris France

9. Department of Emergency Medicine Indiana University School of Medicine Indianapolis IN USA

10. Section of Cardiology, San Francisco Veterans Affairs Medical Center and School of Medicine University of California San Francisco CA USA

11. Cardiology, Department of Medical and Surgical Specialties, Radiologic Sciences, and Public Health University of Brescia Brescia Italy

Funder

Novartis Pharma

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ejhf.2695

Reference26 articles.

1. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

2. Heart failure with mid-range ejection fraction in CHARM: characteristics, outcomes and effect of candesartan across the entire ejection fraction spectrum

3. Regional Variation in Patients and Outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) Trial

4. Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials

5. Empagliflozin in Heart Failure with a Preserved Ejection Fraction

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diversity in heart failure management: Quo Vadis, guideline-directed medical therapy?;International Journal of Cardiology;2024-11

2. Association of Supranormal Left Ventricular Function With Major Adverse Cardiovascular Events: A Systematic Review of Literature;Cardiology in Review;2024-09-05

3. Prevalence and Prognostic Implications of Changes in Tricuspid Regurgitation Severity in Acute Heart Failure;Journal of Cardiac Failure;2024-09

4. Clinical phenotypes of heart failure patients with supranormal ejection fraction;ESC Heart Failure;2024-08-12

5. Lower heart rate in patients with acute heart failure: the role of left ventricular ejection fraction;Scandinavian Cardiovascular Journal;2024-08-08